Scientists have developed a new way to boost stem cell research that will help in numerous therapies using stem cell. The recent development is a new way of growing human embryonic stem cells in the laboratory.
Human embryonic stem cells have the potential to play an important role in regeneration of cells for therapeutic use. However, while in the process of research these are exposed to live animal cells and serum and run the risk of being infected with pathogens. This may lead to future health risks.
The new research has developed an embryonic stem cell line without exposure to cells or serum. Embryo cells were thawed and cultured in the process. Then inner cell masses were separated by surgery and plated onto specially coated plated that may be sterilized. Six embryonic human stem-cell lines were maintained in this serum and feeder free culture procedure. The result was derivation of a new stem cell line from human embryos under new conditions.
The new process evolved out of research is likely to bring about changes in the way stem-cell studies are going on. The research came out in the current issue of The Lancet.